Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rikke Bech

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Case Reports in Dermatology|July 20, 2019
Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic GlucocorticoidKenneth Thomsen, Mette Deleuran, Christian Vestergaard, et al.
Ugeskrift for Laeger|June 1, 2021
[Diagnostic approach of bullous skin disease]Shiva Beck, Jeanette Kaae, Christian Vestergaard, et al.
Ugeskrift for Laeger|October 18, 2022
[Bullous skin diseases]Jeanette Kaae, Rikke Bech, Elisabeth Hjardem Taudorf, et al.
Experimental Dermatology|March 18, 2014
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skinRikke Bech, Kristian Otkjaer, Svend Birkelund, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Molecular and Cellular Therapies|January 29, 2016
Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory moleculesRikke Bech, Babak Jalilian, Ralf Agger, et al.
Frontiers in Oncology|October 22, 2024
RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoidesMaria Danielsen, Thomas Emmanuel, Morten Muhlig Nielsen, et al.
Blood|September 19, 2022
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphomaMaria Gluud, Emil M H Pallesen, Terkild B Buus, et al.
Blood|January 3, 2024
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndromeChella Krishna Vadivel, Andreas Willerslev-Olsen, Martin R J Namini, et al.
Cancer Discovery|June 14, 2025
Divergent Evolution of Malignant Subclones Maintains a Balance Between Induced Aggressiveness and Intrinsic Drug Resistance in T Cell CancerTerkild B Buus, Chella Krishna Vadivel, Maria Gluud, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Case Reports in Dermatology|July 20, 2019
Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic GlucocorticoidKenneth Thomsen, Mette Deleuran, Christian Vestergaard, et al.
Ugeskrift for Laeger|June 1, 2021
[Diagnostic approach of bullous skin disease]Shiva Beck, Jeanette Kaae, Christian Vestergaard, et al.
Ugeskrift for Laeger|October 18, 2022
[Bullous skin diseases]Jeanette Kaae, Rikke Bech, Elisabeth Hjardem Taudorf, et al.
Experimental Dermatology|March 18, 2014
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skinRikke Bech, Kristian Otkjaer, Svend Birkelund, et al.
Acta Dermato-Venereologica|March 13, 2025
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case SeriesSigne Hedebo, Martin B Pedersen, Lise M Lindahl, et al.
Molecular and Cellular Therapies|January 29, 2016
Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory moleculesRikke Bech, Babak Jalilian, Ralf Agger, et al.
Frontiers in Oncology|October 22, 2024
RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoidesMaria Danielsen, Thomas Emmanuel, Morten Muhlig Nielsen, et al.
Blood|September 19, 2022
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphomaMaria Gluud, Emil M H Pallesen, Terkild B Buus, et al.
Blood|January 3, 2024
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndromeChella Krishna Vadivel, Andreas Willerslev-Olsen, Martin R J Namini, et al.
Cancer Discovery|June 14, 2025
Divergent Evolution of Malignant Subclones Maintains a Balance Between Induced Aggressiveness and Intrinsic Drug Resistance in T Cell CancerTerkild B Buus, Chella Krishna Vadivel, Maria Gluud, et al.
Pageof 3